Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

29452 ARTÍCULOS , VIENDO DEL 28291 AL 28305

How prevalent are modifiable dementia risk factors in Ireland? A 12-year observational study in community-dwelling older adults

McGarvey C, Kenny RA, Kennelly S, Sexton D, Briggs R.

BMJ Open. 2025 Nov 11;15(11):e106032. doi: 10.1136/bmjopen-2025-106032.

Delusional Infestation, Psychiatric Comorbidity, and Dementia: A Review of 146 Swedish Patients

Norberg J, Lonne-Rahm SB, Lönndahl L.

Acta Derm Venereol. 2025 Nov 25;105:adv43823. doi: 10.2340/actadv.v105.43823.

Osteoporosis and risk of dementia among older adults: a population‑based cohort study

Wang J, Wang S, Jin C, Li X, Mo C, Zheng J, Lu X, Liang F, Gu D.

Bone Res. 2025 Dec 22;13(1):104. doi: 10.1038/s41413-025-00480-7.

Group interventions for people with primary progressive aphasia and their care partners: Considerations for clinical practice

Volkmer A, Hausmann A, Paplikar A, Battista P, Jokel R; International PPA SLT/P network.

Neuropsychol Rehabil. 2025 Jul;35(6):1254-1282. doi: 10.1080/09602011.2024.2391338. Epub 2024 Aug 30.

Supportive Interventions Involving Family Carers of Patients With Delirium Superimposed on Dementia in Hospital: A Scoping Review

Ashton-Gough C, Lynch J, Goodman C.

Int J Older People Nurs. 2025 Mar;20(2):e70016. doi: 10.1111/opn.70016.

Brexpiprazole: A Balance of Risks and Benefits

Hitt EM.

Sr Care Pharm. 2025 Mar 1;40(3):115-122. doi: 10.4140/TCP.n.2025.115.

Communication Strategies Used in Primary Progressive Aphasia: A Scoping Review

Cadório I, Vieira D.

Dementia (London). 2026 May;25(4):899-924. doi: 10.1177/14713012251356588. Epub 2025 Jul 9.

Emerging Concepts in Diagnosis, Pathologic Features, and Treatment of Limbic-Predominant Amnestic Neurodegenerative Syndrome (LANS): A Narrative Review

Serio MA, Dethloff DR, Curry GC, Beesley ML, Shekoohi S, Kaye AD.

Adv Ther. 2025 Nov;42(11):5300-5312. doi: 10.1007/s12325-025-03337-x. Epub 2025 Aug 29.

Language and psychiatric symptom overlap in FTD: an SLP perspective

Masson-Trottier M.

Int Rev Psychiatry. 2025 Dec;37(8):781-794. doi: 10.1080/09540261.2025.2583258. Epub 2025 Nov 10.

Dementia and communication comorbidities within the context of caregiver support systems: a scoping review

Dhanda N, Scaria EB.

BMC Geriatr. 2025 Dec 4;25(1):995. doi: 10.1186/s12877-025-06622-0.

Cholinergic System Structure and Function Changes in Individuals with Down Syndrome During the Development of Alzheimer's Disease

Russell JK, Conley AC, Wilson JE, Newhouse PA.

Curr Top Behav Neurosci. 2025;69:49-78. doi: 10.1007/7854_2024_523.

What Can We Learn About Alzheimer's Disease from People with Down Syndrome?

Maure-Blesa L, Rodríguez-Baz I, Carmona-Iragui M, Fortea J.

Curr Top Behav Neurosci. 2025;69:197-226. doi: 10.1007/7854_2024_546.

Emerging Pharmacological Approaches for Psychosis and Agitation in Alzheimer's Disease

Imbimbo C, Cotta Ramusino M, Leone S, Mazzacane F, De Franco V, Gatti A, Perini G, Costa A.

CNS Drugs. 2025 Feb;39(2):143-160. doi: 10.1007/s40263-024-01133-9. Epub 2024 Dec 2.

Calcineurin inhibition may prevent Alzheimer disease in people with Down syndrome

Dohl J, Treadwell Z, Norris C, Head E.

Alzheimers Dement. 2025 Mar;21(3):e70034. doi: 10.1002/alz.70034.

Resistance and resilience to Alzheimer's disease in Down syndrome

Boyle R, Koops EA, Ances B, Andrews EJ, Arenaza-Urquijo EM, Bejanin A, Brickman AM, Buckley RF, Clas GS, Costello E, Coughlan GT, Conley AC, Deng F, de Paula Faria D, Edwards N, Flores-Aguilar L, Fortea J, Ghazi Saidi L, Head E, Hom CL, Koenig K, Lao P, Lengyel I, Li YJ, Loi S, Loughrey D, McGlinchey E, Newhouse P, Pertierra L, Prokopiou PC, Qi Q, de Paula França Resende E, Russell J, Scanlon CE, Schneider C, Schultz SA, Seto M, Shaka S, Soldan A, Vaqué Alcázar L, Weng Y, Wilson JE, Zaman SH, Zsadányi SE, Hartley S.

Alzheimers Dement. 2025 Apr;21(4):e70151. doi: 10.1002/alz.70151.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias